Cargando…

The role of inflammation in autoimmune disease: a therapeutic target

Autoimmune diseases (AIDs) are immune disorders whose incidence and prevalence are increasing year by year. AIDs are produced by the immune system’s misidentification of self-antigens, seemingly caused by excessive immune function, but in fact they are the result of reduced accuracy due to the decli...

Descripción completa

Detalles Bibliográficos
Autores principales: Xiang, Yu, Zhang, Mingxue, Jiang, Die, Su, Qian, Shi, Jianyou
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Frontiers Media S.A. 2023
Materias:
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10584158/
https://www.ncbi.nlm.nih.gov/pubmed/37859999
http://dx.doi.org/10.3389/fimmu.2023.1267091
_version_ 1785122693351211008
author Xiang, Yu
Zhang, Mingxue
Jiang, Die
Su, Qian
Shi, Jianyou
author_facet Xiang, Yu
Zhang, Mingxue
Jiang, Die
Su, Qian
Shi, Jianyou
author_sort Xiang, Yu
collection PubMed
description Autoimmune diseases (AIDs) are immune disorders whose incidence and prevalence are increasing year by year. AIDs are produced by the immune system’s misidentification of self-antigens, seemingly caused by excessive immune function, but in fact they are the result of reduced accuracy due to the decline in immune system function, which cannot clearly identify foreign invaders and self-antigens, thus issuing false attacks, and eventually leading to disease. The occurrence of AIDs is often accompanied by the emergence of inflammation, and inflammatory mediators (inflammatory factors, inflammasomes) play an important role in the pathogenesis of AIDs, which mediate the immune process by affecting innate cells (such as macrophages) and adaptive cells (such as T and B cells), and ultimately promote the occurrence of autoimmune responses, so targeting inflammatory mediators/pathways is one of emerging the treatment strategies of AIDs. This review will briefly describe the role of inflammation in the pathogenesis of different AIDs, and give a rough introduction to inhibitors targeting inflammatory factors, hoping to have reference significance for subsequent treatment options for AIDs.
format Online
Article
Text
id pubmed-10584158
institution National Center for Biotechnology Information
language English
publishDate 2023
publisher Frontiers Media S.A.
record_format MEDLINE/PubMed
spelling pubmed-105841582023-10-19 The role of inflammation in autoimmune disease: a therapeutic target Xiang, Yu Zhang, Mingxue Jiang, Die Su, Qian Shi, Jianyou Front Immunol Immunology Autoimmune diseases (AIDs) are immune disorders whose incidence and prevalence are increasing year by year. AIDs are produced by the immune system’s misidentification of self-antigens, seemingly caused by excessive immune function, but in fact they are the result of reduced accuracy due to the decline in immune system function, which cannot clearly identify foreign invaders and self-antigens, thus issuing false attacks, and eventually leading to disease. The occurrence of AIDs is often accompanied by the emergence of inflammation, and inflammatory mediators (inflammatory factors, inflammasomes) play an important role in the pathogenesis of AIDs, which mediate the immune process by affecting innate cells (such as macrophages) and adaptive cells (such as T and B cells), and ultimately promote the occurrence of autoimmune responses, so targeting inflammatory mediators/pathways is one of emerging the treatment strategies of AIDs. This review will briefly describe the role of inflammation in the pathogenesis of different AIDs, and give a rough introduction to inhibitors targeting inflammatory factors, hoping to have reference significance for subsequent treatment options for AIDs. Frontiers Media S.A. 2023-10-04 /pmc/articles/PMC10584158/ /pubmed/37859999 http://dx.doi.org/10.3389/fimmu.2023.1267091 Text en Copyright © 2023 Xiang, Zhang, Jiang, Su and Shi https://creativecommons.org/licenses/by/4.0/This is an open-access article distributed under the terms of the Creative Commons Attribution License (CC BY). The use, distribution or reproduction in other forums is permitted, provided the original author(s) and the copyright owner(s) are credited and that the original publication in this journal is cited, in accordance with accepted academic practice. No use, distribution or reproduction is permitted which does not comply with these terms.
spellingShingle Immunology
Xiang, Yu
Zhang, Mingxue
Jiang, Die
Su, Qian
Shi, Jianyou
The role of inflammation in autoimmune disease: a therapeutic target
title The role of inflammation in autoimmune disease: a therapeutic target
title_full The role of inflammation in autoimmune disease: a therapeutic target
title_fullStr The role of inflammation in autoimmune disease: a therapeutic target
title_full_unstemmed The role of inflammation in autoimmune disease: a therapeutic target
title_short The role of inflammation in autoimmune disease: a therapeutic target
title_sort role of inflammation in autoimmune disease: a therapeutic target
topic Immunology
url https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10584158/
https://www.ncbi.nlm.nih.gov/pubmed/37859999
http://dx.doi.org/10.3389/fimmu.2023.1267091
work_keys_str_mv AT xiangyu theroleofinflammationinautoimmunediseaseatherapeutictarget
AT zhangmingxue theroleofinflammationinautoimmunediseaseatherapeutictarget
AT jiangdie theroleofinflammationinautoimmunediseaseatherapeutictarget
AT suqian theroleofinflammationinautoimmunediseaseatherapeutictarget
AT shijianyou theroleofinflammationinautoimmunediseaseatherapeutictarget
AT xiangyu roleofinflammationinautoimmunediseaseatherapeutictarget
AT zhangmingxue roleofinflammationinautoimmunediseaseatherapeutictarget
AT jiangdie roleofinflammationinautoimmunediseaseatherapeutictarget
AT suqian roleofinflammationinautoimmunediseaseatherapeutictarget
AT shijianyou roleofinflammationinautoimmunediseaseatherapeutictarget